Announced

Henry Schein to acquire Acentus.

Synopsis

Henry Schein, a provider of healthcare products and services, agreed to acquire Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors. “As the delivery of health care in the U.S. is increasingly provided in home-based settings, Henry Schein is strategically expanding our offerings to meet the growing demand. We are pleased to announce our acquisition of Acentus, which enhances our ability to deliver CGM products directly to patients’ homes. With Acentus, we will strengthen our position nationally in the home medical supply market and better serve our valued customers, including clinics, physician practices, health systems, ambulatory surgery centers, and most importantly, patients and families,” Stanley M. Bergman, Henry Schein Chairman of the Board and Chief Executive Officer.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US